Anuh Pharma Limited has informed the Exchange regarding 'Adoption of Memorandum of Association (MOA) and Articles of Association (AOA) as per Companies Act, 2013.'.

Negative operating cash flowResults View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.1%Reaction day

₹81.50

prior close

₹80.81

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-7.2% vs market

Pharmaceuticals peers, median of 160sector+0.2%-6.3% vs sector

On the reaction day the stock moved 7.2 pts less than Nifty Microcap 250 and 6.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.5

10m

-3.5

15m

-4.3

30m

-4.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.1+1.1-7.2+0.2-6.3

Next day

-6.2+1.2-7.4+0.2-6.4

-6.3+2.8-9.1+1.5-7.8

-6.1+3.5-9.7+1.4-7.6

-6.1+3.5-9.6+1.6-7.7

-6.1+2.8-9.0+1.0-7.2

-7.5+2.8-10.3+0.4-7.9

15d

-2.5+4.2-6.7+0.7-3.2

-3.2+10.1-13.3+3.1-6.3

-1.4+10.0-11.4+7.2-8.6

-6.3+14.6-20.8+8.2-14.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma Limited reported FY2025-26 results with revenue from operations growing 16.6% YoY to Rs. 77,165.74 Lakhs. However, profit after tax declined 13.3% to Rs. 4,104.61 Lakhs, while EBITDA margin compressed from 10.64% to 8.56%. Operating cash flow turned negative at Rs. -301.16 Lakhs (vs +Rs. 3,712.47 Lakhs in prior year). Inventories nearly doubled to Rs. 14,775.50 Lakhs. The Board recommended a dividend of Rs. 1.50 per share (30% payout). Nine promoter group members (holding 0.95% shares) sought reclassification to public category. The company also approved new MOA/AOA, appointed new internal auditors (RMJ & Associates LLP), and a new GM-Quality.

Likely market impact

Despite revenue growth, the sharp decline in profitability, margin compression, and negative operating cash flow signal operational stress. Shareholders may face pressure on returns despite the dividend recommendation.

By the numbersStandalone · Q4 FY26 vs Q4 FY25

	Q4 FY26	Q4 FY25	Change
Revenue	₹202.1 Cr	₹198.1 Cr	+2.0%
Operating profit	₹16.77 Cr	₹15.88 Cr	+5.6%
Profit after tax	₹11.68 Cr	₹12.46 Cr	−6.2%
EBITDA margin	9.8%	9.4%	+0.4 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.